Drugs.com: More naloxone orders filled when pharmacists can dispense
UC research on naloxone dispensing makes headlines across the country
Pharmacy researchers at the University of Cincinnati unveiled an impactful research study on Jan. 31, 2020 that shows an association between a 2015 Ohio law and a surge in the dispensing of naloxone in Ohio pharmacies. Naloxone is the anti-overdose drug and pharmacists here can now legally dispense it in the state, without a prescription.
While the study focused solely on the increase in distribution of this lifesaving medication, the implications are that death rates by overdose drop up to 14% in states where access is increased. As the opioid crisis continues to plague the U.S. and other countries, reporters from national, regional and local outlets took great interest in the study. The college dean, Neil MacKinnon, and lead faculty researcher, Pamela Heaton, participated in both televsion and print media interviews within days of the study's release.
A sample of the widespread interest includes:
- USA Today: News from around our 50 states
- Drugs.com: More Naloxone Orders Filled When Pharmacists Can Dispense
- U.S. News and World Report: Study: Naloxone Dispensing Increased More Than 2,000%
- AP: Study: Naloxone dispensing increased more than 2,000%
- UPI: Naloxone sales up 2,300% in Ohio after law loosens pharmacist restrictions
- WBNS: Study: Naloxone dispensing in Ohio increased more than 2,000% since 2015
Featured image: generic pharmacy purchases/unsplash.com/Tbel Abuseridze
Related Stories
Cancer Center expert urges lung cancer screenings as too few at-risk patients get tested
September 4, 2026
The University of Cincinnati Cancer Center's Robert Van Haren, MD, spoke with Local 12 about the need for more awareness and discussions around lung cancer screenings.
Apply for 2027 Presidential Medal Awards
September 4, 2026
UC President Neville Pinto invites eligible students to apply for two of our university’s top awards — the PLME & PMGSE.
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.